Revelation Biosciences Inc (REVB) Stock Price, Quote & News

Company Profile

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 800 3717

Website: www.revbiosciences.com

Address:

4660 La Jolla Village Drive, Suite 100, San Diego, United States

TradingDreamz Feb. 3 at 10:39 PM

$REVB yeah this is going to atleast 3 dollars soon

0 · Reply

Perlaksen Feb. 3 at 9:51 PM

$REVB and bounce up to 0.70. shows how explosive it can move up with just a little volume

0 · Reply

Donniechen12345 Feb. 3 at 9:46 PM

$REVB it will keep falling slowly to $1 …. good thing the MM doesnt knife this down too fast , or else everyone would exit too early , instead they all will exit around $1 and under…:(

0 · Reply

Donniechen12345 Feb. 3 at 9:38 PM

$REVB $1.53’ouch

0 · Reply

revuelto Feb. 3 at 8:48 PM

$REVB prepare for either another offering at a significantly reduced price or a delisting…whatever happens first...this company was essentially created to drain money from retail investors and that will become clear eventually✌️

0 · Reply

Perlaksen Feb. 3 at 8:23 PM

$REVB

0 · Reply

Donniechen12345 Feb. 3 at 7:53 PM

$REVB but now lets get back to that $11,400,000 warrants , they stilll need to sell another $7,400,000 scam shares to be filled . keep filling the gap and buy more lmao $$$$ the more you buy the more it will drop until that warrants are all filled lol will keep falling 5-15% every day :(

1 · Reply

Donniechen12345 Feb. 3 at 7:47 PM

$REVB by the tine some news comes out this will be at .50cents and rot lmao

0 · Reply

biotech_as Feb. 3 at 7:37 PM

$REVB This is what matters (FDA is onboard)-> Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI. Management raised money to work on Phase 2/3. Shorts purpose is to create fear and force people to sell for a loss. Management is putting all the pieces together to start Phase 2/3 trials. From their recent PR "Over the course of 2026, Revelation will continue to build the infrastructure required to successfully conduct this clinical study, including engagement of a top-tier clinical research organization specializing in hospital-based renal studies, establishing an expert panel of scientific advisors, and completing the manufacture of clinical drug supply. Revelation is working expeditiously toward initiating the Phase 2/3 study." This stock can easily go crazy when the news is out that they are starting to enroll and dose patients. Donnie can collect his pennies by creating fear.

1 · Reply

Perlaksen Feb. 3 at 7:30 PM

$REVB $SPY $BTC.X $ETH.X

0 · Reply

Revelation Biosciences Inc. Announces 1-for-4 Reverse Stock Split Effective January 28, 2026

Jan 23, 2026, 2:10 PM EST - 11 days ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds

Jan 21, 2026, 8:30 AM EST - 13 days ago

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI

Jan 14, 2026, 9:00 AM EST - 20 days ago

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

Jan 12, 2026, 5:00 PM EST - 22 days ago

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jan 7, 2026, 9:00 AM EST - 27 days ago

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

Dec 1, 2025, 9:00 AM EST - 2 months ago

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

Nov 20, 2025, 9:00 AM EST - 2 months ago

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

Nov 6, 2025, 4:15 PM EST - 3 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

Oct 29, 2025, 9:00 AM EDT - 3 months ago

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

Oct 15, 2025, 5:00 PM EDT - 3 months ago

Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025

Sep 11, 2025, 8:30 AM EDT - 5 months ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds

Sep 10, 2025, 7:20 AM EDT - 5 months ago

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

Sep 9, 2025, 4:55 PM EDT - 5 months ago

Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

Sep 9, 2025, 8:00 AM EDT - 5 months ago

Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

Aug 8, 2025, 6:30 AM EDT - 6 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025

Jul 24, 2025, 9:00 AM EDT - 6 months ago

Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research

Jul 16, 2025, 9:00 AM EDT - 7 months ago

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

Jul 1, 2025, 5:26 PM EDT - 7 months ago

Revelation Biosciences Inc. Announces 1-for-3 Reverse Stock Split Effective July 7, 2025

May 29, 2025, 4:05 PM EDT - 8 months ago

Revelation Biosciences, Inc. Announces Closing of $4 Million Public Offering

May 29, 2025, 8:00 AM EDT - 8 months ago

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

May 23, 2025, 4:05 PM EDT - 9 months ago

Revelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors

May 8, 2025, 4:15 PM EDT - 9 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2025

Apr 29, 2025, 9:00 AM EDT - 10 months ago

Revelation Biosciences to Develop Gemini for Infection in Severe Burn Patients

Mar 17, 2025, 6:00 AM EDT - 11 months ago

Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells

Mar 13, 2025, 6:00 AM EDT - 11 months ago

Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

Mar 6, 2025, 4:15 PM EST - 11 months ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024

Feb 26, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Feb 24, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval

Jan 24, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025

Jan 21, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

Jan 13, 2025, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025

Jan 6, 2025, 6:00 AM EST - 1 year ago

Nasdaq Grants Revelation Biosciences Inc. Continued Listing

Dec 3, 2024, 8:38 AM EST - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds

Dec 2, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND

Nov 12, 2024, 6:00 AM EST - 1 year ago

Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply

Nov 8, 2024, 4:15 PM EST - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024

Sep 24, 2024, 6:00 AM EDT - 1 year ago

Revelation Biosciences' Gemini Induces Dose Dependent Significant Increases in IL-10

Aug 21, 2024, 5:30 PM EDT - 1 year ago

Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024

Jun 24, 2024, 9:00 AM EDT - 1 year ago

Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity

Jun 13, 2024, 9:21 AM EDT - 1 year ago

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini

May 10, 2024, 4:52 PM EDT - 1 year ago

Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024

Mar 22, 2024, 4:15 PM EDT - 2 years ago

Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023

Mar 13, 2024, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)

Mar 12, 2024, 9:00 AM EDT - 2 years ago

Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference

Mar 4, 2024, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini

Feb 13, 2024, 9:00 AM EST - 2 years ago

Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)

Feb 9, 2024, 8:35 AM EST - 2 years ago

Top 5 Health Care Stocks That Are Preparing To Pump In February

CNSP GILD ZLAB

Feb 5, 2024, 4:41 PM EST - 2 years ago

Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering

TradingDreamz Feb. 3 at 10:39 PM

$REVB yeah this is going to atleast 3 dollars soon

0 · Reply

Perlaksen Feb. 3 at 9:51 PM

$REVB and bounce up to 0.70. shows how explosive it can move up with just a little volume

0 · Reply

Donniechen12345 Feb. 3 at 9:46 PM

$REVB it will keep falling slowly to $1 …. good thing the MM doesnt knife this down too fast , or else everyone would exit too early , instead they all will exit around $1 and under…:(

0 · Reply

Donniechen12345 Feb. 3 at 9:38 PM

$REVB $1.53’ouch

0 · Reply

revuelto Feb. 3 at 8:48 PM

0 · Reply

Perlaksen Feb. 3 at 8:23 PM

$REVB

0 · Reply

Donniechen12345 Feb. 3 at 7:53 PM

1 · Reply

Donniechen12345 Feb. 3 at 7:47 PM

$REVB by the tine some news comes out this will be at .50cents and rot lmao

0 · Reply

biotech_as Feb. 3 at 7:37 PM

1 · Reply

Perlaksen Feb. 3 at 7:30 PM

$REVB $SPY $BTC.X $ETH.X

0 · Reply

ieatbaguette Feb. 3 at 7:30 PM

$ELPW $SMX Remember me? >>> $REVB

1 · Reply

Perlaksen Feb. 3 at 7:29 PM

$REVB

0 · Reply

Perlaksen Feb. 3 at 7:29 PM

$REVB

0 · Reply

Perlaksen Feb. 3 at 7:28 PM

$REVB the only reason sp falling is stoploss hunting by shortdick donnie

0 · Reply

Perlaksen Feb. 3 at 7:25 PM

$REVB its easy to understand shortdick Donnie is full of lies

0 · Reply

Donniechen12345 Feb. 3 at 7:12 PM

$REVB but but they have $22,000,000 in cash now … market cap $3 mil ……. should be $7 bux per shares right ??? smh youre an idiot thinking like that smh ….. that $22,000,000 that they just scammed investors , NOT one penny goes into the stock price !!!!!!!!! unless they announc a Pr saying we will repurchase company shares with that stolen $22 mil, otherwise this stock is worthless soon, they cashed out and left you rookies investors bankrupt . how hard is that to understand!!!!!!!!!! hate donnie all you want for speaking the truth , but dont hate your money!!!!!!! wth mannn smh…. you need to stay away from this scam ponzi stock :(

0 · Reply

Perlaksen Feb. 3 at 7:10 PM

$REVB

1 · Reply

Perlaksen Feb. 3 at 7:06 PM

$REVB the usual short Donnie nonsens

0 · Reply

Donniechen12345 Feb. 3 at 7:06 PM

$REVB $1.69 !!!! Donnie right again smh ……. $1 soon

0 · Reply

Donniechen12345 Feb. 3 at 6:38 PM

$REVB another $8,000,000 scam warrants left that needs to be filled ,, keep buying rookies lol

1 · Reply

Donniechen12345 Feb. 3 at 6:30 PM

$REVB someone will need to fund that $11,000,000 scam offering , 400 % of market cap and also that $11,400,000 warrants , it AINt FREE !!!!! rookies LONGS will use their account $$$$$$ to pay for that $22,000,000 and it aint coming from DONNiES account LOL….. stay away from this scam stock lol. last one holding will feel like shiett once this drops to $1 soon ouch!!!

0 · Reply

Donniechen12345 Feb. 3 at 6:23 PM

$REVB it can only hold for so long , eventually the knife will comes smh , got out and stay away from this scam company!!!!! hate donnie all you want , but dont hate your money lol

0 · Reply

Market Cap	3.22M
Revenue (ttm)	0.00
Net Income (ttm)	-15.04M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	411,500
Avg Vol	704,754
Day's Range	N/A - N/A
Shares Out	1.58M
Stochastic %K	1%
Beta	-0.14
Analysts	Strong Sell
Price Target	$85.00